Search
For Your SweetHeart Survey
For Your SweetHeart | Campaign Facts
Prescription digital therapeutics and mental health care
eeo_is_the_law
EEO is the Law Poster
Athens
eeo_is_the_law
The BI Cares Patient Assistance Program - Editable Form
The BI Cares Patient Assistance Program - Gilotrif® - Fillable Form
The BI Cares Patient Assistance Program - Ofev® - Fillable Form
The BI Cares Patient Assistance Program
The BI Cares Patient Assistance Program - Gilotrif®
The BI Cares Patient Assistance Program - Ofev®
Equitable access to Prescription Digital Therapeutics
Evolution of prescription digital therapeutics
All Other Locations New Hire
Athens New Hire
INBUILD® meets primary endpoint: study evaluated Ofev® in patients across a range of progressive fibrosing interstitial lung diseases
INBUILD® meets primary endpoint: study evaluated Ofev® in patients across a range of progressive fibrosing interstitial lung diseases
Six creative Connecticut students turn aspiring ideas into inventive innovation
Learn about the 2023 Connecticut Invention Convention winners.
An Employee’s Commitment to Ensuring Access to Medicines
An Employee’s Commitment to Ensuring Access to Medicines
OFEV® (nintedanib) Data in Patients with ILDs | Boehringer Ingelheim US
Studies from American Thoracic Society Congress show the proportion of patients with 10% or greater declines in lung function were lower in the OFEV group.
Real-world data announced for adults with type 2 diabetes
Two analyses of the U.S. data from the EMPRISE real-world study show that Jardiance (empagliflozin) tablets was associated with a reduction in risk of hospitalization for heart failure compared with two other classes of glucose-lowering therapies in adult
Boehringer Ingelheim Launches External Innovation Hub in China
Boehringer Ingelheim Launches External Innovation Hub in China
Creating an Inclusive Workplace for Employees with Disabilities
Creating an Inclusive Workplace for Employees with Disabilities